Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study

Abstract

Objective

To investigate the psychometric properties of the Multiple Sclerosis Impact Scale (MSIS-29) and to assess the relationship between the Kurtzke Expanded Disability Status Scale and the physical and psychological parts of this score.

Methods

A population-based study identified cases with definite multiple sclerosis (MS) in the north-east region of Ireland. They were examined and completed the MSIS-29. Cases were classified as mild (Expanded Disability Status Score (EDSS) 0–3.0), moderate (EDSS 3.5–5.5), or severe (6.0–9.5) MS.

Results

The 248 participants (82 male, 166 female) had a mean age of 49.1 years (SD 12.4). EDSS ranged from 0 to 9.5 (median 6.0). Data quality was excellent (0.02% missing data), physical and psychological scores spanned the entire range with low floor and ceiling effects. Internal consistency was high (Cronbach’s alpha 0.97 – physical score, 0.93 – psychological score). The convergent validity of the physical impact score of the MSIS-29 with the Kurtzke EDSS was confirmed with a high Spearman’s rank coefficient correlation of 0.63 (P = 0.01). Physical impact scores for mild, moderate, and severe disability as were statistically different at 25.9%, 48.0%, and 63.9%, respectively. Mean psychological score was non-significantly higher in the moderately disabled group at 47.4% compared with the severely disabled at 44.3% (P = 0.58).

Conclusions

The MSIS-29 is an acceptable, reliable, and valid method of recording quality of life. A significant relationship between higher physical impact scores of the MSIS-29 and higher Kurtzke EDSS values suggests that is may be of use in clinical trials to monitor progression.

Keywords

multiple sclerosis multiple sclerosis impact scale (MSIS-29)quality of life

Get full access to this article

View all access options for this article.

References

1 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

2 Sharrack B Hughes RA Soudain S Dunn G . The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141–159.

3 Hobart J Freeman J Thompson A . Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000; 123: 1027–1040.

4 Amato MP Ponziani G . Quantification of impairment in MS: discussion of the scales in use. Mult Scler 1999; 5: 216–219.

5 Noseworthy JH Vandervoort MK Wong CJ Ebers GC . Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 1990; 40: 971–975.

6 Ware JE Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

7 Vickrey BG Hays RD Harooni R Myers LW Ellison GW . A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187–206.

8 Cella DF Dineen K Arnason B . Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129–139.

9 LaRocca NG Ritivo PG Miller DM Fischer JS Andrews H Paty DW . “Quality of life” assessment in multiple sclerosis clinical trials: current status and strategies for improving multiple sclerosis clinical trial design. In: DE Goodkin RA Rudick , (eds), Multiple sclerosis: advances in clinical trial design, treatment and future perpectives. London: Springer-Verlag; 1996. p. 145–160.

10.

10 Pfennings LE Van der Ploeg HM Cohen L . A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurol Scand 1999; 100: 148–155.

11.

11 Hobart J Lamping D Fitzpatrick R Riazi A Thompson A . The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962–973.

12.

12 Riazi A Hobart JC Lamping DL Fitzpatrick R Thompson AJ . Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 2003; 9: 411–419.

13.

13 Hoogervorst EL Zwemmer JN Jelles B Polman CH Uitdehaag BM . Multiple sclerosis impact scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 2004; 10: 569–574.

14.

14 McGuigan C Hutchinson M . The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry 2004; 75: 266–269.

15.

15 Hobart JC Riazi A Lamping DL Fitzpatrick R Thompson AJ . How responsive is the multiple sclerosis impact scale (MSIS-29)? A comparison with some other elf reported scales. J Neurol Neurosurg Psychiatry 2005; 76: 1539–1543.

16.

16 Gray OM McDonnell GV Hawkins SA . Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Mult Scler 2008; 14: 880–886.

17.

17 Poser CM Paty DW Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

18.

18 McDonald WI Compston A Edan G . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

19.

19 McHorney CA Ware JE . Construction and validation of an alternate form general mental health scale for the Medical Outcomes Study Short-Form 36-Item Health Survey. Med Care 1995; 33: 15–28.

20.

20 Costelloe L O’Rourke K Kearney H . The patient knows best: significant change in the physical component of the multiple sclerosis impact scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 2007; 78: 841–844.